Mitochondria-targeted esculetin alleviates mitochondrial dysfunction by AMPK-mediated nitric oxide and SIRT3 regulation in endothelial cells: potential implications in atherosclerosis
Santosh Karnewar(University of Virginia), Srigiridhar Kotamraju(Indian Institute of Chemical Technology)
Cited by 60
Related Papers
Mitochondria‐targeted esculetin inhibits PAI‐1 levels by modulating STAT3 activation and miR‐19b via SIRT3: Role in acute coronary artery syndrome
|Journal of Cellular Physiology|2017|34
Fluvastatin Mediated Breast Cancer Cell Death: A Proteomic Approach to Identify Differentially Regulated Proteins in MDA-MB-231 Cells
|PLoS ONE|2014|22
Treatment of advanced atherosclerotic mice with the senolytic agent ABT-263 is associated with reduced indices of plaque stability and increased mortality
|bioRxiv (Cold Spring Harbor Laboratory)|2023|2